PAV-220830FLY-555

samples-publishAS-BCG_PAV.xlsx

PAV-220830FLY-555

23119-191004

NHP-220830FLY-78

infusion premed administered 30 minutes prior to infusion. , pre-dosing vitals; HR 154, RR 32, T 98. Interim vitals; HR 160, RR 30, T 99.0. End of infusion vitals; HR 160,RR 32, T 99.9. No adverse reactions. , pre-dosing vitals; HR 154, RR 32, T 98. Interim vitals; HR 160, RR 30, T 99.0. End of infusion vitals; HR 160, RR 32, T 99.9. No adverse reactions. , infusion premed administered 30 minutes prior to infusion.

https://fairdomhub.org/sops/795

Blood; Treatment

Fluorescence Activated Cell Sorting; Complete Blood Count Blood Test

Flynn Lab

2019-10-04 00:00:00

JoAnne Flynn

Acetaminophen

Medication

Orally

80

milligram

Anti CD8

Antibody

Intravenously

335(32milliliter)

milligram

Anti CD8A

Antibody

Intravenously

335

milligram

Diphenhydramine

Medication

Intramuscularly

8

milligram

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

AB-220907FLY-3

Not specified

help Creators and Submitter
Creators
Not specified
Submitter
Activity

Views: 10

Created: 3rd Feb 2025 at 21:09

Last updated: 4th Feb 2025 at 00:35

help Tags

This item has not yet been tagged.

help Attributions

None

Powered by
(v.1.16.1)
Copyright © 2008 - 2024 The University of Manchester and HITS gGmbH